According to a new report by Polaris Market Research, the global castrate-resistant prostate cancer (CRPC) market was valued at USD 12.92 billion in 2024 and is projected to reach USD 29.79 billion by 2034, expanding at a CAGR of 8.7% from 2025 to 2034. Growth is underpinned by rising prostate cancer incidence, an expanding geriatric population, and accelerating innovation in hormonal...

Polaris Market Research has published insightful research on Castrate-Resistant Prostate Cancer Market. The research report offers an in-depth analysis of the market, covering all the major aspects, including market size, market share, growth drivers, and key trends. Besides, a thorough assessment of the annual forecast, strategies, and potential roadmaps has been provided in the...

In an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...

The Japan Prostate Cancer Imaging Market is valued at USD 345.5 million in 2023 and is expected to reach USD 438.0 million by 2030, with a CAGR of 3.4% from 2024 to 2030.   This growth is fueled by the rising cases of prostate cancer among Japan's aging male population and the increased awareness of early detection through improved imaging solutions like MRI, PET-CT, and ultrasound fusion...

The Japan Prostate Cancer Imaging Market is valued at USD 345.5 million in 2023 and is expected to reach USD 438.0 million by 2030, with a CAGR of 3.4% from 2024 to 2030.   This growth is fueled by the rising cases of prostate cancer among Japan's aging male population and the increased awareness of early detection through improved imaging solutions like MRI, PET-CT, and ultrasound fusion...

The global Prostate Cancer market is a dynamic and promising industry that has shown significant growth in recent years. According to Kings Research recent market study, the Prostate Cancer market was valued at USD 12.72 billion in 2025 and is expected to reach USD 21.45 billion by 2032, exhibiting a robust CAGR of 7.74% over the forecast period of 2025-2032. This report provides a...

The global Prostate Cancer market is a dynamic and promising industry that has shown significant growth in recent years. According to Kings Research recent market study, the Prostate Cancer market was valued at USD 12.72 billion in 2025 and is expected to reach USD 21.45 billion by 2032, exhibiting a robust CAGR of 7.74% over the forecast period of 2025-2032. This report provides a...

The Prostate Cancer Treatment Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Prostate Cancer Treatment Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive landscape, and...

Global Prostate Cancer Treatment Market Overview: Latest Trends, Industry Size, Share and Growth Projection “Markntel Advisors – Leading Market Research Company” has recently conducted a comprehensive examination of the Global Prostate Cancer Treatment Market, encompassing the forecast period from 2022-27. Utilizing data from the historical period of 2017-20,...

According to a new report by Polaris Market Research, the global prostate cancer treatment market was valued at USD 15.17 billion in 2025 and is projected to reach USD 31.60 billion by 2034, expanding at a CAGR of 8.5% over the forecast period. Growth is underpinned by the rising prevalence of prostate cancer, expanding adoption of precision diagnostics, and accelerating...